Literature DB >> 26742680

Is there a role for telemedicine in adult allergy services?

M T Krishna1,2, R C Knibb2, A P Huissoon1.   

Abstract

Telemedicine refers to the application of telecommunication and information technology (IT) in the delivery of health and clinical care at a distance or remotely and can be broadly considered in two modalities: store-and-forward and real-time interactive services. Preliminary studies have shown promising results in radiology, dermatology, intensive care, diabetes, rheumatology and primary care. However, the evidence is limited and hampered by small sample sizes, paucity of randomized control studies and lack of data relating to cost-effectiveness, health-related quality of life and patient and clinician satisfaction. This review appraises the evidence from studies that have employed telemedicine tools in other disciplines and makes suggestions for its potential applications in specific clinical scenarios in adult allergy services. Possible examples include: triaging patients to determine the need for allergy tests; pre-assessment for specialized treatments such as allergen immunotherapy, follow-up to assess treatment response and side effects; and education in self-management plan including training updates for self-injectable adrenaline and nasal spray use. This approach might improve access for those with limited mobility or living far away from regional centres, as well as bringing convenience and cost savings for the patient and service provider. These potential benefits need to be carefully weighed against evidence of service safety and quality. Keys to success include delineation of appropriate clinical scenarios, patient selection, training, IT support and robust information governance framework. Well-designed prospective studies are needed to evaluate its role.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26742680     DOI: 10.1111/cea.12701

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

Review 1.  Telehealth in Primary Health Care: A Scoping Review of the Literature.

Authors:  Leila Beheshti; Leila R Kalankesh; Leila Doshmangir; Mostafa Farahbakhsh
Journal:  Perspect Health Inf Manag       Date:  2022-01-01

Review 2.  Systematic review of pathways for the delivery of allergy services.

Authors:  Lavanya Diwakar; Carole Cummins; Richard Lilford; Tracy Roberts
Journal:  BMJ Open       Date:  2017-02-07       Impact factor: 2.692

Review 3.  Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model.

Authors:  Giacomo Malipiero; Enrico Heffler; Corrado Pelaia; Francesca Puggioni; Francesca Racca; Sebastian Ferri; Lina Spinello; Morena Merigo; Donatella Lamacchia; Giuseppe Cataldo; Melissa Sansonna; Giorgio Walter Canonica; Giovanni Paoletti
Journal:  Clin Transl Allergy       Date:  2020-06-18       Impact factor: 5.871

4.  Googling Allergy in Ireland: Content Analysis.

Authors:  Catherine King; Ciaran Judge; Aideen Byrne; Niall Conlon
Journal:  J Med Internet Res       Date:  2020-05-13       Impact factor: 5.428

5.  More room for telemedicine after COVID-19: lessons for primary care?

Authors:  Livio Garattini; Marco Badinella Martini; Michele Zanetti
Journal:  Eur J Health Econ       Date:  2020-11-24

6.  Telemedicine in allergy/immunology in the era of COVID-19: a Canadian perspective.

Authors:  Sarah Edgerley; Rongbo Zhu; Ariba Quidwai; Harold Kim; Samira Jeimy
Journal:  Allergy Asthma Clin Immunol       Date:  2022-02-21       Impact factor: 3.406

7.  Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science-Based Study.

Authors:  Ashley J Housten; Uzoma Charles Okere; Graham A Colditz; Cynthia Ma; Jingxia Liu; Courtney Harriss; Nancy U Lin; Melissa Rooney; Jennifer Dill; Muhammad Popalzai; Jennifer Badiu; Kan Huang; Casey Burton; Lindsay Peterson
Journal:  JMIR Res Protoc       Date:  2022-07-25

8.  Improving primary care in Europe beyond COVID-19: from telemedicine to organizational reforms.

Authors:  Livio Garattini; Marco Badinella Martini; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2020-11-16       Impact factor: 3.397

9.  Synchronous Telemedicine in Allergy: Lessons Learned and Transformation of Care During the COVID-19 Pandemic.

Authors:  Iason Thomas; Leonard Q C Siew; Krzysztof Rutkowski
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10-19

10.  COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.

Authors:  Oliver Pfaar; Ludger Klimek; Marek Jutel; Cezmi A Akdis; Jean Bousquet; Heimo Breiteneder; Sharon Chinthrajah; Zuzana Diamant; Thomas Eiwegger; Wytske J Fokkens; Hans-Walter Fritsch; Kari C Nadeau; Robyn E O'Hehir; Liam O'Mahony; Winfried Rief; Vanitha Sampath; Manfred Schedlowski; María José Torres; Claudia Traidl-Hoffmann; De Yun Wang; Luo Zhang; Matteo Bonini; Randolf Brehler; Helen Annaruth Brough; Tomás Chivato; Stefano R Del Giacco; Stephanie Dramburg; Radoslaw Gawlik; Aslı Gelincik; Karin Hoffmann-Sommergruber; Valerie Hox; Edward F Knol; Antti Lauerma; Paolo M Matricardi; Charlotte G Mortz; Markus Ollert; Oscar Palomares; Carmen Riggioni; Jürgen Schwarze; Isabel Skypala; Eva Untersmayr; Jolanta Walusiak-Skorupa; Ignacio J Ansotegui; Claus Bachert; Anna Bedbrook; Sinthia Bosnic-Anticevich; Luisa Brussino; Giorgio Walter Canonica; Victoria Cardona; Pedro Carreiro-Martins; Alvaro A Cruz; Wienczyslawa Czarlewski; João A Fonseca; Maia Gotua; Tari Haahtela; Juan Carlos Ivancevich; Piotr Kuna; Violeta Kvedariene; Désirée Erlinda Larenas-Linnemann; Amir Hamzah Abdul Latiff; Mika Mäkelä; Mário Morais-Almeida; Joaquim Mullol; Robert Naclerio; Ken Ohta; Yoshitaka Okamoto; Gabrielle L Onorato; Nikolaos G Papadopoulos; Vincenzo Patella; Frederico S Regateiro; Bolesław Samoliński; Charlotte Suppli Ulrik; Sanna Toppila-Salmi; Arunas Valiulis; Maria-Teresa Ventura; Arzu Yorgancioglu; Torsten Zuberbier; Ioana Agache
Journal:  Allergy       Date:  2021-03       Impact factor: 14.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.